Scarica l'app Stockscreener
0.352
1.03%
0.0036
Precedente Chiudi:
$0.3484
Aprire:
$0.342
Volume 24 ore:
225.91K
Relative Volume:
0.11
Capitalizzazione di mercato:
$11.72M
Reddito:
$476.00K
Utile/perdita netta:
$-38.52M
Rapporto P/E:
-0.3893
EPS:
-0.9041
Flusso di cassa netto:
$-39.89M
1 W Prestazione:
-5.98%
1M Prestazione:
-2.90%
6M Prestazione:
-64.80%
1 anno Prestazione:
-87.86%
Intervallo 1D:
$0.342
$0.3659
Intervallo di 1 settimana:
$0.342
$0.40
Portata 52W:
$0.2805
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Nome
Vyne Therapeutics Inc
Settore
Industria
Telefono
800-775-7936
Indirizzo
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Confronta VYNE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.352 | 11.60M | 476.00K | -38.52M | -39.89M | -0.9041 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-31 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-11-18 | Iniziato | BTIG Research | Buy |
| 2021-12-06 | Ripresa | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Borsa (VYNE) Ultime notizie
Can VYNE Therapeutics Inc. stock sustain market leadershipWeekly Earnings Recap & AI Powered Buy/Sell Recommendations - newser.com
Will VYNE Therapeutics Inc. stock continue dividend increasesVolume Spike & Fast Moving Stock Watchlists - newser.com
Why analysts remain bullish on VYNE Therapeutics Inc. stockWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
Is VYNE Therapeutics Inc. stock near bottom after declinePortfolio Gains Report & Consistent Profit Trade Alerts - newser.com
Will VYNE Therapeutics Inc. stock benefit from sector rotationTake Profit & Risk Adjusted Swing Trade Ideas - newser.com
Can VYNE Therapeutics Inc. stock withstand economic slowdownEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
How VYNE Therapeutics Inc. stock performs during Fed tightening cyclesJuly 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Understanding VYNE Therapeutics Inc.’s price movementProfit Target & Free Growth Oriented Trading Recommendations - newser.com
Will VYNE Therapeutics Inc. stock maintain momentum in 2025Portfolio Gains Report & Risk Controlled Stock Pick Alerts - newser.com
What high frequency data says about VYNE Therapeutics Inc.Trade Exit Report & Growth Focused Entry Reports - newser.com
Signal strength of VYNE Therapeutics Inc. stock in tech scannersMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Is VYNE Therapeutics Inc. showing signs of accumulationJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
What Wall Street predicts for VYNE Therapeutics Inc. stock price2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Tools to monitor VYNE Therapeutics Inc. recovery probabilityMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com
Can swing trading help recover from VYNE Therapeutics Inc. lossesEarnings Risk Summary & High Accuracy Buy Signal Tips - newser.com
Is VYNE Therapeutics Inc. stock undervalued vs historical averagesRisk Management & Daily Profit Focused Screening - newser.com
Why VYNE Therapeutics Inc. stock is seen as undervaluedMarket Growth Summary & Weekly Breakout Watchlists - newser.com
Vyne Therapeutics Inc Azioni (VYNE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):